VMP 10970311000001105

Search dm+d | Analyse prescribing for this drug | See prices paid for this drug and its variants

Name Irbesartan 300mg / Hydrochlorothiazide 25mg tablets
BNF code 0205052A0AAACAC
Virtual Therapeutic Moiety Irbesartan + Hydrochlorothiazide
Basis of preferred name Other
Prescribing status Valid as a prescribable product
Sugar free
Gluten free
Preservative free
CFC free
Dose form Discrete
Unit dose form size 1.000
Unit dose form units tablet
Unit dose unit of measure tablet
Virtual Product Ingredient
Ingredient Irbesartan
Basis of pharmaceutical strength Based on Ingredient Substance
Strength value numerator 300.000
Strength value numerator unit mg
Virtual Product Ingredient
Ingredient Hydrochlorothiazide
Basis of pharmaceutical strength Based on Ingredient Substance
Strength value numerator 25.000
Strength value numerator unit mg
Ontology Drug Form & Route
Form & Route tablet.oral
Dose Form
Formulation Oral tablet
Drug Route
Route Oral
Controlled Drug Prescribing Information
Controlled Drug category No Controlled Drug Status
Actual Medicinal Products
Irbesartan 300mg / Hydrochlorothiazide 25mg tablets (A A H Pharmaceuticals Ltd)
Irbesartan 300mg / Hydrochlorothiazide 25mg tablets (Accord-UK Ltd)
Irbesartan 300mg / Hydrochlorothiazide 25mg tablets (Alliance Healthcare (Distribution) Ltd)
Irbesartan 300mg / Hydrochlorothiazide 25mg tablets (Bristol Laboratories Ltd)
Irbesartan 300mg / Hydrochlorothiazide 25mg tablets (Brown & Burk UK Ltd)
Irbesartan 300mg / Hydrochlorothiazide 25mg tablets (Macleods Pharma UK Ltd)
Irbesartan 300mg / Hydrochlorothiazide 25mg tablets (Medihealth (Northern) Ltd)
Irbesartan 300mg / Hydrochlorothiazide 25mg tablets (Milpharm Ltd)
Irbesartan 300mg / Hydrochlorothiazide 25mg tablets (Sigma Pharmaceuticals Plc)
Virtual Medicinal Product Packs
Irbesartan 300mg / Hydrochlorothiazide 25mg tablets 28 tablet

dm+d data retrieved from TRUD: release NHSBSA_4.4.0_20240429000001, imported on 29th April 2024 at 05:07:25.

Feedback